BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
OCG
Oriental Culture Holding Ltd.
There isn't enough reported data to score OCG yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
OCG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
OCG's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
OCG PE Valuation
OCG has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
OCG Forward outlook
There aren't enough analyst estimates for OCG to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over OCG in the latest year-over-year earnings comparison.
OCG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$107.26 | +$11.54 |
| Q4 2024 | -$118.80 | +$435.60 |
| Q4 2023 | -$554.40 | -212% |
OCG has swung to a loss: it lost $107.26 per share over the past year, after a profit the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over OCG in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
OCG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $1.9M | +203% |
| Q4 2024 | $622.7K | -61% |
| Q4 2023 | $1.6M | -91% |
| Q4 2022 | $17.8M | -53% |
| Q4 2021 | $37.6M | +116% |
| Q4 2020 | $17.4M | +212% |
| Q4 2019 | $5.6M | +4.6% |
OCG's revenue has slid since its 2021 peak: $2M last quarter, down 95% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -203% | -232 points |
| Q4 2024 | -513% | -523 points |
| Q4 2023 | -274% | -322 points |
| Q4 2022 | 15% | -66 points |
| Q4 2021 | 29% | -21 points |
| Q4 2020 | 9.4% | N/A |
| Q4 2019 | 48% | N/A |
| Q2 2019 | 80% | N/A |
OCG's operating margin was −203% last quarter, down 232 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
OCG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$4.1M | -218% |
| Q4 2023 | $3.4M | +$5.4M |
| Q4 2022 | -$1.9M | -$1.3M |
| Q4 2021 | -$573.5K | -107% |
| Q4 2020 | $8.1M | +302% |
| Q4 2019 | $2M | -36% |
| Q2 2019 | $7.3M | +9184% |
| Q4 2018 | $3.1M | +7928% |
OCG's free cash flow has turned negative after years in the green: −$3M over the past year.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over OCG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
OCG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +79% | +15.9K shares |
| 1 year | +479% | +29.8K shares |
OCG has 35,968 diluted shares, up 479% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
| Q2 2019 | — |
| Q4 2018 | $125 |
| Q2 2018 | — |
| Q4 2017 | — |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
OCG Net Leverage
OCG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
OCG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.6 | Oversold |
| Stochastic | 30.4 | Neutral |
OCG's weekly RSI is 25 (oversold) and its Stochastic is 30 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
OCG PE vs Consumer Cyclical Sector
| Metric | OCG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
OCG has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
OCG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.63 | 0.6% below |
| 20 week MA | $1.64 | 1.2% below |
| 50 week MA | $46.0 | 96% below |
| 100 week MA | $1,165.0 | 100% below |
| 200 week MA | $1,218.6 | 100% below |
OCG is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over OCG on returns for 2026, with the stronger performance.
OCG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19,800.0 | $17,886.0 | -9.7% |
| 2021 | $17,886.0 | $16,632.0 | -7% |
| 2022 | $16,632.0 | $1,881.0 | -89% |
| 2023 | $1,881.0 | $943.8 | -50% |
| 2024 | $943.8 | $772.2 | -18% |
| 2025 | $772.2 | $56.8 | -93% |
| 2026 YTD | $56.8 | $1.62 | -97% |
OCG has finished every year since 2020 lower, and it's down 97% so far in 2026.